Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-134875
Filing Date
2025-06-04
Accepted
2025-06-04 16:02:02
Documents
5
Effectiveness Date
2025-06-04

Document Format Files

Seq Description Document Type Size
1 S-8 d50939ds8.htm S-8 39035
2 EX-5.1 d50939dex51.htm EX-5.1 7159
3 EX-23.1 d50939dex231.htm EX-23.1 1584
4 EX-FILING FEES d50939dexfilingfees.htm EX-FILING FEES 15216
5 GRAPHIC g50939g0529073304532.jpg GRAPHIC 2639
  Complete submission text file 0001193125-25-134875.txt   67800
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287765 | Film No.: 251023053
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)